Skip to main content
Article thumbnail
Location of Repository

Applying health economics for policy decision making: how much do devices differ from drugs?

By Corinna Sorenson, Rosanna Tarricone, Markus Siebert and Michael Drummond

Abstract

Medical devices pose unique challenges for economic evaluation and associated decision-making processes that differ from pharmaceuticals. We highlight and discuss these challenges in the context of cardiac device therapy, based on a systematic review of relevant economic evaluations. Key challenges include practical difficulties in conducting randomized clinical trials, allowing for a 'learning curve' and user characteristics, accounting for the wider organizational impacts of introducing new devices, and allowing for variations in product characteristics and prices over time

Topics: HB Economic Theory, RA Public aspects of medicine
Publisher: Oxford University Press
Year: 2011
DOI identifier: 10.1093/europace
OAI identifier: oai:eprints.lse.ac.uk:31644
Provided by: LSE Research Online
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://europace.oxfordjournals... (external link)
  • http://eprints.lse.ac.uk/31644... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.